Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

ea0063ns1.2 | (1) | ECE2019

Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring

Morganstein Daniel

Checkpoint Inhibitors have emerges as a major breakthrough in cancer therapy. Side effects are largely immune mediated, termed immune related adverse events. Whilst the majority of these respond to immunosuppressive treatment, most frequently glucocorticoids, endocrinopathies are amongst the more frequent adverse events, and usually lead to permanent hormone deficiency, requiring life long hormone replacement. There are differences in the pattern of endocrinopathy between diff...

ea0063mtne1 | (1) | ECE2019

Nursing approach to the holistic care of patients with intellectual disability

Northway Ruth

People with intellectual disabilities are known to face many inequalities in healthcare that lead to poor health as well as premature and preventable death. They often experience multiple comorbidities, often at a younger age than the wider population, and often these include endocrine disorders. However, many of the barriers they face to accessing timely and appropriate health care are preventable and/or their impact can be reduced. This presentation aims to highlight both th...

ea0063npd2 | (1) | ECE2019

Testosterone replacement: ‘The best practice’.

Hawkins A. , Casey E. , Nikookam K.

Testosterone deficiency syndrome (TDS) may well contribute to a number of co morbidities and multitude of symptoms which may affect one’s daily activities adversely. TDS prevalence in UK is 1:500 and certain groups of patient’s are at higher risk of TDS, in particular elderly and patients with diabetes mellitus where 42% are known to have TDS. A retrospective audit was carried out to bench mark our practice in line with a publication of a recommended National/Europea...

ea0063npd2.1 | (1) | ECE2019

Hypoparathyroidism: Aetiology, diagnosis and challenges in management

Heck Ansgar

Hypoparathyroidism is an endocrine disease resulting in hypocalcemia due to inappropriately low circulating parathyroid hormone levels. It is defined as an orphan disease by the European Commission, and commonly managed by endocrinologists and endocrine units. All healthcare personnel involved in the management of patients with chronic hypoparathyroidism should have knowledge about symptoms, treatment and potential complications.Causes: In adults, hypopa...